1-211663507-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_002497.4(NEK2):āc.1257T>Cā(p.Ala419=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.00095 ( 0 hom., cov: 33)
Exomes š: 0.00010 ( 0 hom. )
Consequence
NEK2
NM_002497.4 synonymous
NM_002497.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.117
Genes affected
NEK2 (HGNC:7745): (NIMA related kinase 2) This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 1-211663507-A-G is Benign according to our data. Variant chr1-211663507-A-G is described in ClinVar as [Benign]. Clinvar id is 782234.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.117 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEK2 | NM_002497.4 | c.1257T>C | p.Ala419= | synonymous_variant | 8/8 | ENST00000366999.9 | NP_002488.1 | |
NEK2 | NM_001204182.2 | c.1111+3599T>C | intron_variant | NP_001191111.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEK2 | ENST00000366999.9 | c.1257T>C | p.Ala419= | synonymous_variant | 8/8 | 1 | NM_002497.4 | ENSP00000355966 | P1 | |
NEK2 | ENST00000540251.5 | c.1111+3599T>C | intron_variant | 1 | ENSP00000440237 | |||||
NEK2 | ENST00000462283.5 | n.697T>C | non_coding_transcript_exon_variant | 5/5 | 2 | |||||
NEK2 | ENST00000489633.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000933 AC: 142AN: 152222Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
142
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000231 AC: 58AN: 250804Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135586
GnomAD3 exomes
AF:
AC:
58
AN:
250804
Hom.:
AF XY:
AC XY:
21
AN XY:
135586
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461642Hom.: 0 Cov.: 33 AF XY: 0.0000908 AC XY: 66AN XY: 727126
GnomAD4 exome
AF:
AC:
148
AN:
1461642
Hom.:
Cov.:
33
AF XY:
AC XY:
66
AN XY:
727126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000945 AC: 144AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.00109 AC XY: 81AN XY: 74488
GnomAD4 genome
AF:
AC:
144
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
81
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | - - |
NEK2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 15, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at